Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

20 trials with published results (14%)

Research Maturity

106 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.0%

3 terminated out of 147 trials

Success Rate

97.2%

+10.7% vs benchmark

Late-Stage Pipeline

7%

10 trials in Phase 3/4

Results Transparency

19%

20 of 106 completed with results

Key Signals

20 with results97% success

Data Visualizations

Phase Distribution

98Total
Not Applicable (60)
Early P 1 (1)
P 1 (17)
P 2 (10)
P 3 (5)
P 4 (5)

Trial Status

Completed106
Unknown17
Withdrawn8
Recruiting6
Not Yet Recruiting5
Terminated3

Trial Success Rate

97.2%

Benchmark: 86.5%

Based on 106 completed trials

Clinical Trials (147)

Showing 20 of 20 trials
NCT04141202Recruiting

Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder

NCT01036685CompletedPrimary

Cognitive Task Development and Implementation for Functional MRI Studies

NCT01036581Not ApplicableRecruitingPrimary

Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

NCT07039539Not ApplicableNot Yet RecruitingPrimary

Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

NCT00787423Completed

Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population

NCT05067387Phase 1Not Yet RecruitingPrimary

Evaluation of Oral THC and CBD in Men and Women

NCT07641712Not Yet RecruitingPrimary

General Well-being After Quitting Drug Use

NCT03918850Phase 3Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers

NCT07552623Not ApplicableCompleted

Adapted RPM-08 for Substance Use Disorder in Pakistan

NCT05037487Phase 1CompletedPrimary

Evaluation of Smoked THC and CBD in Men and Women

NCT03911739Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

NCT03911466Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

NCT06134882Not ApplicableActive Not Recruiting

OUD Smartphone Services

NCT02604277Not ApplicableRecruiting

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

NCT04822987Active Not Recruiting

Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs)

NCT04007666Not ApplicableCompleted

Leveraging Implementation Science to Increase Access to Trauma Treatment for Incarcerated Drug Users

NCT05918601Not ApplicableRecruiting

Peer-led Personalized Support Program

NCT06262347Not ApplicableCompleted

Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD

NCT02682225Phase 1CompletedPrimary

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

NCT05877742Not ApplicableRecruitingPrimary

AA on Drug Abusers by Nursing Students

Scroll to load more

Research Network

Activity Timeline